Clinical trial Recruiting at 4 sites Interventional Ages 48 Months to 71 Months

Understanding brain changes in children with developmental language disorder

Official title: Neuroimaging Reveals Treatment-related Changes in DLD

Run by University of Cincinnati · NCT05268341 · Data updated 2026-11-12

This study is trying to see how treatment affects grammar learning in preschoolers with developmental language disorder by looking at their brain changes before and after therapy.

Quick facts

Study typeInterventional
Ages48 Months to 71 Months
SexAll
Enrollment100 (estimated)
SponsorUniversity of Cincinnati
Academic / other
Locations6 sites (Cincinati, Ohio and 5 other locations)
StatusRecruiting
StartedMay 24, 2022
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedMay 26, 2026
Trial IDNCT05268341 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are preschool-aged children (48-71 months) with developmental language disorder who are typically developing in other areas.

Probably not a fit

Patients who are currently receiving other speech-language interventions or have special education placements based on ability or behavior may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research investigates the neural mechanisms underlying grammar learning in preschoolers with developmental language disorder (DLD) using neuroimaging techniques such as functional MRI and diffusion imaging. By examining both functional and structural connectivity in the brain, the study aims to identify how treatment impacts grammar learning and the associated memory-language mechanisms. The project focuses on children aged 48-71 months who exhibit expressive grammar deficits, with the goal of informing more individualized interventions for DLD. The study will gather data before, after, and following treatment to assess changes in brain function and structure related to grammar learning.

Why it matters

Potential benefit: If successful, this study could lead to more effective, tailored interventions for children with developmental language disorder, improving their educational and occupational outcomes.

How similar studies have gone: While the approach of using neuroimaging to understand language disorders is gaining traction, this specific investigation into the neural basis of DLD in preschoolers is relatively novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ages 48-71 months
* average nonverbal intelligence quotient (IQ)
* enrolled in participating center
* typically developing (receptive and expressive language, social, articulation, other)
* DLD for expressive grammar
* typical oral motor function
* typical social/pragmatics skills
* average hearing thresholds
* monolingual and native Standard English speakers
* does not have any uncorrected vision challenges

Exclusion Criteria:

* receiving co-occurring speech-language or other intervention for communication
* not MRI safe
* special education placement of child based on ability or behavior

Where it's running

  • Empower Learn Create INC
    Cincinnati, Ohio, United States
    Recruiting
  • CWFF CHild Development Center
    Cincinnati, Ohio, United States
    Recruiting
  • Wesley Education Center for Children and Families
    Cincinnati, Ohio, United States
    Recruiting
  • University of Cincinnati
    Cincinnati, Ohio, United States
    Recruiting
  • New Horizon Childcare
    Cincinati, Ohio, United States
    Not yet recruiting
  • Cincinnati Children's Hospital
    Cincinnati, Ohio, United States
    Not yet recruiting

Study contacts

  • Principal investigator: Karla N Washington, PhD — University of Cincinnati
  • Study coordinator: Karla N Washington, PhD
  • Email: washink2@ucmail.uc.edu
  • Phone: 513-558-8533

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.